Human Genetics

, Volume 119, Issue 6, pp 604–610

X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology

  • Amy J. Clark
  • Efraim H. Rosenberg
  • Ligia S. Almeida
  • Tim C. Wood
  • Cornelis Jakobs
  • Roger E. Stevenson
  • Charles E. Schwartz
  • Gajja S. Salomons
Original Investigation

Abstract

Mutations in the creatine transporter gene, SLC6A8 (MIM 30036), located in Xq28, have been found in families with X-linked mental retardation (XLMR) as well as in males with idiopathic mental retardation (MR). In order to estimate the frequency of such mutations in the MR population, a screening of 478 males with MR of unknown cause was undertaken. All 13 exons of SLC6A8 were sequenced using genomic DNA. Six novel potentially pathogenic mutations were identified that were not encountered in at least 588 male control chromosomes: two deletions (p.Asn336del, p.Ile347del) and a splice site alteration (c.1016+2C>T) are considered pathogenic based on the nature of the variant. A mutation (p.Arg391Trp) should be considered pathogenic owing to its localization in a highly conserved region. Two other missense variants (p.Lys4Arg, p.Gly26Arg) are not conserved but were not observed in over 300 male control chromosomes. Their pathogenicity is uncertain. A missense variant (p.Val182Met), was classified as a polymorphism based on a normal creatine/creatinine (Cr:Crn) ratio and cerebral creatine signal in proton magnetic resonance spectroscopy (H-MRS) in the patient. Furthermore, we found 14 novel intronic and neutral variants that were not encountered in at least 280 male control chromosomes and should be considered as unclassified variants. Our findings of a minimum of four pathogenic mutations and two potentially pathogenic mutations indicate that about 1% of males with MR of unknown etiology might have a SLC6A8 mutation. Thus, DNA sequence analysis and/or a Cr:Crn urine screen is warranted in any male with MR of unknown cause.

Keywords

Creatine transporter X-linked mental retardation Non-fragile X MR 

References

  1. Almeida LS, Verhoeven NM, Roos B, Valongo C, Cardoso ML, Vilarinho L, Salomons GS, Jakobs C (2004) Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol Genet Metab 82:214–219PubMedCrossRefGoogle Scholar
  2. Bizzi A, Bugiani M, Salomons GS, Hunneman DH, Moroni I, Estienne M, Danesi U, Jakobs C, Uziel G (2002) X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8. Ann Neurol 52:227–231PubMedCrossRefGoogle Scholar
  3. Cecil KM, Salomons GS, Ball WS, Jr., Wong B, Chuck G, Verhoeven NM, Jakobs C, Degrauw TJ (2001) Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol 49:401–404PubMedCrossRefGoogle Scholar
  4. Degrauw TJ, Salomons GS, Cecil KM, Chuck G, Newmeyer A, Schapiro MB, Jakobs C (2002) Congenital creatine transporter deficiency. Neuropediatrics 33:232–238PubMedCrossRefGoogle Scholar
  5. Degrauw TJ, Cecil KM, Byars AW, Salomons GS, Ball WS, Jakobs C (2003) The clinical syndrome of creatine transporter deficiency. Mol Cell Biochem 244:45–48PubMedCrossRefGoogle Scholar
  6. Dodd JR, Christie DL (2001) Cysteine 144 in the third transmembrane domain of the creatine transporter is located close to a substrate-binding site. J Biol Chem 276:46983–46988PubMedCrossRefGoogle Scholar
  7. Dodd JR, Christie DL (2005) Substituted-cysteine accessibility of the third transmembrane domain of the creatine transporter: Defining a transport pathway. J Biol Chem 280:32649–32654PubMedCrossRefGoogle Scholar
  8. Hahn KA, Salomons GS, Tackels-Horne D, Wood TC, Taylor HA, Schroer RJ, Lubs HA, Jakobs C, Olson RL, Holden KR, Stevenson RE, Schwartz CE (2002) X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. Am J Hum Genet 70:1349–1356PubMedCrossRefGoogle Scholar
  9. Mancini GM, Catsman-Berrevoets CE, de Coo IF, Aarsen FK, Kamphoven JH, Huijmans JG, Duran M, van der Knaap MS, Jakobs C, Salomons GS (2005) Two novel mutations in SLC6A8 cause creatine transporter defect and distinctive X-linked mental retardation in two unrelated Dutch families. Am J Med Genet A 132:288–295Google Scholar
  10. Mandel JL (2004) Comparative frequency of fragile-X (FMR1) and creatine transporter (SLC6A8) mutations in X-linked mental retardation. Am J Hum Genet 75:730–731PubMedCrossRefGoogle Scholar
  11. Mandel JL, Chelly J (2004) Monogenic X-linked mental retardation: is it as frequent as currently estimated? The paradox of the ARX (Aristaless X) mutations. Eur J Hum Genet 12:689–693PubMedCrossRefGoogle Scholar
  12. Rosenberg EH, Almeida LS, Kleefstra T, deGrauw RS, Yntema HG, Bahi N, Moraine C, Ropers HH, Fryns JP, Degrauw TJ, Jakobs C, Salomons GS (2004) High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet 75:97–105PubMedCrossRefGoogle Scholar
  13. Salomons GS, van Dooren SJ, Verhoeven NM, Cecil KM, Ball WS, Degrauw TJ, Jakobs C (2001) X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 68:1497–1500PubMedCrossRefGoogle Scholar
  14. Salomons GS, van Dooren SJ, Verhoeven NM, Marsden D, Schwartz C, Cecil KM, Degrauw TJ, Jakobs C (2003) X-linked creatine transporter defect: an overview. J Inherit Metab Dis 26:309–318PubMedCrossRefGoogle Scholar
  15. Schiaffino MC, Bellini C, Costabello L, Caruso U, Jakobs C, Salomons GS, Bonioli E (2005) X-linked creatine transporter deficiency. Clinical description of a patient with a novel SLC6A8 gene mutation. Neurogenetics 1–4Google Scholar
  16. Stepp ML, Cason AL, Finnis M, Mangelsdorf M, Holinski-Feder E, MacGregor D, MacMillan A, Holden JJ, Gecz J, Stevenson RE, Schwartz CE (2005) XLMR in MRX families 29, 32, 33 and 38 results from the dup24 mutation in the ARX (Aristaless related homeobox) gene. BMC Med Genet 6:16PubMedCrossRefGoogle Scholar
  17. Stevenson RE, Schwartz CE (2002) Clinical and molecular contributions to the understanding of X-linked mental retardation. Cytogenet Genome Res 99:265–275PubMedCrossRefGoogle Scholar
  18. Stevenson RE, Schwartz CE, Schroer RJ (2000) X-Linked mental retardation. Oxford University Press, New YorkGoogle Scholar
  19. Stockler-Ipsiroglu S, Salomons GS (2006) Cerebral creatine deficiency syndromes. In: Fernandes J, Saudubray JM, Walter JH, Van den Berghe G (eds) Inborn metabolic diseases—diagnosis and treatment, 4th edn. Springer, Berlin Heidelberg New York (in press)Google Scholar
  20. Stromberger C, Bodamer OA, Stockler-Ipsiroglu S (2003) Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism. J Inherit Metab Dis 26:299–308PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Amy J. Clark
    • 1
  • Efraim H. Rosenberg
    • 2
  • Ligia S. Almeida
    • 2
  • Tim C. Wood
    • 1
  • Cornelis Jakobs
    • 2
  • Roger E. Stevenson
    • 1
  • Charles E. Schwartz
    • 1
  • Gajja S. Salomons
    • 2
  1. 1.J.C. Self Research InstituteGreenwood Genetic CenterGreenwoodUSA
  2. 2.Department of Clinical Chemistry, Metabolic UnitVU University Medical CenterAmsterdamThe Netherlands

Personalised recommendations